carcinoma

(redirected from Clear cell carcinoma)
Also found in: Dictionary, Thesaurus, Medical.
Related to Clear cell carcinoma: clear cell adenocarcinoma, Clear Cell Sarcoma, Renal cell carcinoma

carcinoma:

see neoplasmneoplasm
or tumor,
tissue composed of cells that grow in an abnormal way. Normal tissue is growth-limited, i.e., cell reproduction is equal to cell death. Feedback controls limit cell division after a certain number of cells have developed, allowing for tissue repair
..... Click the link for more information.
.

carcinoma

[‚kärs·ən′ō·mə]
(medicine)
A malignant epithelial tumor.

carcinoma

Pathol
1. any malignant tumour derived from epithelial tissue
2. another name for cancer
References in periodicals archive ?
2: Cumulative 5-year incidence of recurrence (a) and cancer-specific survival (b) for metformin and non-metformin users with clear cell carcinoma.
This is further complicated by their immunohistochemical staining profiles because both clear cell carcinoma of the gallbladder and metastatic clear cell RCC in the gallbladder are positive for cytokeratin and epithelial membrane antigen.
Clear cell carcinoma represents the main differential diagnosis for atypical endometriosis because of the nuclear atypia, hobnail appearance, and association with endometriotic cysts.
Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of diseases, announced today that it has moved to expand its Phase 2 clinical trial for its drug candidate ENMD-2076 in advanced ovarian clear cell carcinoma (OCCC) with the submission of a new drug global clinical trial application with China's Food and Drug Administration (CFDA).
Pigmented renal clear cell carcinoma with melanocytic differentiation.
EntreMed is currently conducting a Phase 2 study of ENMD-2076 in triple-negative breast cancer, a Phase 2 study in advanced/metastatic soft tissue sarcoma, and expecting to initiate a Phase 2 study in ovarian clear cell carcinoma.
6-9) Mutations of CTNNB1, the gene encoding [beta]-catenin, are common in endometrioid adenocarcinomas but are rare in serous, mucinous, and clear cell carcinomas.
Relevant clinical history includes a personal history of clear cell carcinoma of the ovary 8 years earlier and a paternal grandfather diagnosed with prostate cancer at 70 years old.
In contrast, most of those with endometrioid or clear cell carcinoma presented with pelvic pain or abnormal vaginal bleeding with or without a pelvic mass (Fertil.
Clear cell carcinoma of the ovary (CCCO) is a distinct histopathologic subtype of epithelial ovarian tumors and accounts for <5% of all ovarian malignancies (1).
The tumour is characterised by large cells with abundant granular to fluffy cytoplasm with well-defined cell borders and perinuclear clearing (1-9) leading to confusion with clear cell carcinoma and oncocytoma.